Author

Kaiser Health News

Browsing

Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.

States are required to set up transportation to medical appointments for adults, children and people with disabilities enrolled in the Medicaid program, and contracts can be worth tens of millions of dollars for transportation companies. But patients say the companies that deliver those rides are showing up late — and sometimes not at all — leaving them in bad weather, disrupting their care and even causing injuries.